Burjeel Medical City
Burjeel Medical City is a JCI-accredited quaternary care hospital in Abu Dhabi — the flagship of Burjeel Holdings — operating a 1.2 million sq ft, 350+ bed campus with 60+ specialties, advanced robotic and imaging technology, and dedicated international patient services for complex care and medical tourism.
- Company typePrivate
- Founded2022
- HeadquartersAbu Dhabi, United Arab Emirates
- Headcount1,001–5,000
- GTM typeB2C
- OfferingServices
What Burjeel Medical City does
Burjeel Medical City is a JCI-accredited quaternary care hospital in Abu Dhabi and the flagship facility of publicly listed Burjeel Holdings. Operated across a 1.2 million sq ft campus with 350+ beds and 60+ medical specialties, the hospital is structured as a multi-institute complex — including the Cancer, Transplant, Orthopedic, Neuroscience, ENT/Head & Neck, Advanced Gynecology, Maternal Fetal, and Eye Institutes, alongside centers for Sarcoma & Bone, Neuro-Oncology, Thyroid & Parathyroid, Thalassemia & Sickle Cell, and rehabilitation services delivered through Himmah. Its technology stack is built around premium capital equipment: a da Vinci Xi robotic surgical system, Zeiss surgical microscopes (Kinevo 900, Tivato 700, Opmi Lumer 700), Brainlab navigation, Elekta Versa HD radiation therapy, intraoperative MRI 1.5T and 3T, PET-CT and SPECT-CT hybrid imaging, a dual-plane catheterization lab, and a 3D breast imaging system.
The hospital generates revenue primarily through fee-for-service patient care across inpatient, outpatient, surgical, and diagnostic service lines, supplemented by insurance reimbursements from eight named network partners (GlobeMed, Vidal, Afiya, Oman Insurance, NAS, Neuron, SAICO, GIG) and a premium-priced international patient concierge serving medical tourists from 50+ countries. Specialized institutes command higher unit economics via complex procedures such as liver and kidney transplants, robotic-assisted and uniportal lung surgery, HAIP chemotherapy for liver cancer, endometriosis surgery via the French IFEM Endo partnership, and Paley-method limb reconstruction. Distribution combines walk-in and appointment access for UAE residents, insurance network participation, dedicated international patient services, medical tourism referral partnerships across MENA, Africa, and Eastern Europe, and an MoU with the UAE Ministry of Foreign Affairs for diplomatic referrals. In FY2022 the hospital generated AED 741 million in revenue (~USD 202 million), up 125% year-over-year, contributing approximately 20% of the group's hospital segment revenue.
Burjeel Medical City firmographics
Firmographics- Name
- Burjeel Medical City
- Legal name
- Burjeel Hospital
- Website
- https://burjeelmedicalcity.com
- Company type
- Private
- Founded year
- 2022
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- Burjeel Medical City is a JCI-accredited quaternary care hospital in Abu Dhabi — the flagship of Burjeel Holdings — operating a 1.2 million sq ft, 350+ bed campus with 60+ specialties, advanced robotic and imaging technology, and dedicated international patient services for complex care and medical tourism.
- Ownership category
- akta.pro rank
Burjeel Medical City industry classification
Industry- Product category
- Quaternary Healthcare Services
- NAICS
- General Medical and Surgical Hospitals (622110)
- SIC
- Services-General Medical & Surgical Hospitals, Nec (8062)
- akta.pro primary industry
- International/Medical Tourism Hospital Systems (HLAFAAAN)
- akta.pro secondary industry
- Oncology & Cancer Specialty Hospitals (HLAFAHAC)
Keywords
Where Burjeel Medical City is headquartered
LocationHeadquarters
- HQ city
- Abu Dhabi
- HQ country
- United Arab Emirates
- HQ region
- Middle East
Offices1 record
Markets served
Burjeel Medical City business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Infrastructure, Operations, Technology or R&D, Supply Chain, Marketing or Sales
Revenue model
- Patient Care Services: Primary revenue stream from medical procedures, surgeries, consultations, diagnostic services, and inpatient/outpatient care across 60+ medical specialties. Revenue is generated through fee-for-service arrangements with both self-pay and insured patients, with hospital accommodation charges and treatment costs as core components.
- Diagnostics and Laboratory Services: Revenue from comprehensive diagnostic testing including pathology, radiology, imaging, and laboratory analysis services. CAP-accredited laboratory ensures quality standards for test reliability.
- International Patient Services: Specialized services for medical tourists including visa coordination, airport transfers, accommodation arrangements, and language interpretation. Premium pricing for international patients seeking quaternary care.
- Insurance Reimbursements: Revenue from insurance partnerships with providers including GlobeMed, Vidal, Afiya, Oman Insurance, NAS, Neuron, SAICO, and GIG. Reimbursement based on negotiated contract rates for covered services.
- Specialized Institute Services: Premium services from specialized institutes including oncology (ESMO-accredited), neurosciences, orthopedics, cardiac sciences, and gastroenterology with advanced treatment protocols.
Go-to-market motion3 records
Distribution channels5 records
Marketing channels6 records
Burjeel Medical City product offering
Product offeringCore offering
Burjeel Medical City is a JCI-accredited quaternary care hospital in Abu Dhabi providing advanced medical, surgical, and diagnostic services across 60+ specialties. The facility delivers complex care including robotic-assisted surgery, organ transplantation (liver, kidney, bone marrow), oncology, neurosciences, orthopedics, cardiac sciences, and gynecology through dedicated specialized institutes, while serving both UAE residents and international medical tourists.
Product overview
Burjeel Medical City is a JCI-accredited quaternary care hospital in Abu Dhabi offering over 60 specialized medical disciplines across more than 350 beds. The facility operates as a multi-institute medical complex featuring specialized institutes (Cancer, Orthopedic, Neuroscience, Transplant, ENT/Head & Neck, Advanced Gynecology, Maternal Fetal), specialized centers (Sarcoma & Bone, Neuro-Oncology, Eye, Thyroid & Parathyroid, Thalassemia & Sickle Cell, Sleep Medicine/Dream), and rehabilitation services (Himmah). The hospital deploys advanced medical technologies including da Vinci Xi robotic surgery, Zeiss surgical microscopes, Brainlab navigation systems, Elekta Versa HD radiation therapy, PET-CT/SPECT-CT imaging, and intraoperative MRI. Digital services include a Patient Portal and mobile application for appointment booking and medical records access.
Differentiator
Problem solved
Functional benefit
Products and services
- Advanced Gynecology Institute
Quantifiable outcome
- Successfully treats patients from over 50 countries
- +1 more outcomes
Companies that use Burjeel Medical City
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles3 records
Burjeel Medical City technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Burjeel Medical City partnerships and signals
Strategic signalPartnerships
14 partnerships are on record, tiered core and minor.
- Oftalvist Group (Spain)coreStrategic collaboration with Oftalvist Group from Spain for ophthalmology services. The partnership brings Spanish expertise in eye care and treatments to Burjeel Medical City patients, enhancing the hospital's ophthalmology capabilities with international best practices.
- Dr. Dror PaleycoreEstablishment of Paley Middle East Clinic for limb reconstruction at Burjeel Medical City. Dr. Dror Paley, a world-renowned limb reconstruction specialist, brings advanced techniques for treating complex orthopedic conditions and limb abnormalities to the Middle East region.
- IFEM Endo (France)corePartnership with IFEM Endo from France to establish a center of excellence for endometriosis treatment. French medical expertise in endometriosis diagnosis and management is transferred to serve patients in the UAE and wider region.
- Leejam Sports CompanyminorJoint venture with Leejam Sports Company to develop sports healthcare services in Saudi Arabia. Partnership focuses on providing specialized medical services for athletes and sports-related injuries in the Saudi market.
- Oxford University / Said Business SchoolcoreClimate partnership with Oxford University's Said Business School focusing on sustainability initiatives and environmental responsibility in healthcare operations. Collaboration on climate action strategies and sustainable healthcare practices.
- UAE Ministry of Foreign AffairscoreMoU with UAE Ministry of Foreign Affairs for providing medical services to nationals, residents, and diplomatic community members referred through official diplomatic channels. Formalizes access to government-referred patients.
- GlobeMedcoreInsurance network partnership for providing cashless healthcare services to GlobeMed-insured patients. Enables direct billing and pre-authorization for covered medical treatments.
- VidalcoreInsurance network partnership for providing cashless healthcare services to Vidal-insured patients. Integration with insurance claims processing systems.
- AfiyacoreInsurance network partnership enabling Afiya policyholders to access hospital services with direct billing arrangements.
- Oman InsurancecoreInsurance network partnership with Oman Insurance for providing cashless medical services to policyholders across all covered treatment categories.
- NAScoreInsurance network partnership with NAS for cashless healthcare services and streamlined claims processing.
- NeuroncoreInsurance network partnership with Neuron for providing healthcare services to Neuron-insured patients with direct billing capabilities.
- SAICOcoreInsurance network partnership with SAICO for cashless medical services and comprehensive coverage for SAICO policyholders.
- GIGcoreInsurance network partnership with GIG for providing healthcare services to GIG-insured patients with streamlined authorization and claims processes.
Scale indicators5 records
Recent moves8 records
Expansion highlights4 records
Burjeel Medical City competitors and assessment
Company assessmentEmerging players
- Moorfields Eye Hospital Abu Dhabi: UK-Moorfields-affiliated specialty ophthalmology hospital in Abu Dhabi; directly competes with Burjeel Eye Institute within the same city for ophthalmology referrals and medical-tourism eye patients.
- Sidra Medicine: Qatar Foundation-backed specialty hospital focused on women, children, and complex care; comparable specialty hospital model with academic-medicine orientation competing for GCC quaternary referrals.
Direct peers
- Cleveland Clinic Abu Dhabi: UAE-based quaternary and tertiary academic medical center with US-Cleveland Clinic affiliation, multi-specialty institutes, robotic surgery, transplant, and oncology programs — directly competes with BMC for high-acuity international and domestic patients in Abu Dhabi.
- Sheikh Shakhbout Medical City (SSMC): Flagship quaternary hospital in Abu Dhabi operated in partnership with Mayo Clinic; multi-specialty referral center with oncology, transplant, and advanced surgical programs competing head-to-head with BMC for complex case mix in the emirate.
- King's College Hospital London – Dubai: UK-NHS-affiliated premium multi-specialty hospital in Dubai Hills serving medical tourists and UAE residents across 60+ specialties; targets the same GCC/expat premium patient pool as BMC.
- American Hospital Dubai: Premium multi-specialty private hospital in Dubai with JCI accreditation, robotic surgery, oncology, and transplant services; long-standing medical-tourism destination competing with BMC for international patients.
Broad incumbents
- Mediclinic Middle East: Largest private hospital operator in UAE with multiple facilities across Dubai, Abu Dhabi, and Al Ain; broader portfolio but offers overlapping quaternary and tertiary services in oncology, cardiology, and orthopedics.
- NMC Healthcare: UAE-born hospital group with multi-specialty facilities across the Emirates; despite recent restructuring, remains a primary competitor for insured and self-pay patients across Burjeel's core specialties.
- King Faisal Specialist Hospital & Research Centre: Saudi Arabia's leading quaternary academic medical center for oncology, transplant, and complex care; represents the gold-standard regional competitor for cross-border medical-tourism referrals.
Regional players
- Saudi German Hospitals Group: Largest private hospital network in Saudi Arabia with multi-specialty capacity and a growing premium tier; relevant comparable for BMC's Saudi expansion ambitions via the Leejam JV.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Burjeel Medical City compliance and trust
Trust signalCompliance11 records
Burjeel Medical City financial estimates
Financial estimateRevenue estimate
Valuation estimate
Burjeel Medical City leadership team
Management profileNumber of profiles
Profiles8 records
Burjeel Medical City subsidiaries and ownership
Company hierarchySubsidiaries15 records
Burjeel Medical City funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Burjeel Medical City M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Burjeel Medical City
What does Burjeel Medical City do?
Burjeel Medical City is a JCI-accredited quaternary care hospital in Abu Dhabi providing advanced medical, surgical, and diagnostic services across 60+ specialties. The facility delivers complex care including robotic-assisted surgery, organ transplantation (liver, kidney, bone marrow), oncology, neurosciences, orthopedics, cardiac sciences, and gynecology through dedicated specialized institutes, while serving both UAE residents and international medical tourists.
Is Burjeel Medical City a public or private company?
Burjeel Medical City is a private company. It is classified as corporate owned and is currently operating.
When was Burjeel Medical City founded?
Burjeel Medical City was founded in 2022. It employs 1,001 to 5,000 people.
Where is Burjeel Medical City based?
Burjeel Medical City is headquartered in Abu Dhabi, United Arab Emirates, in the Middle East region.
How does Burjeel Medical City make money?
Five revenue lines are on record. Patient Care Services are the primary driver. The others are diagnostics and Laboratory Services, international Patient Services, insurance Reimbursements and specialized Institute Services.
Who are Burjeel Medical City's main competitors?
Emerging players on record are Moorfields Eye Hospital Abu Dhabi and Sidra Medicine. Direct peers are Cleveland Clinic Abu Dhabi, Sheikh Shakhbout Medical City (SSMC), King's College Hospital London – Dubai and American Hospital Dubai. Broad incumbents are Mediclinic Middle East, NMC Healthcare and King Faisal Specialist Hospital & Research Centre. Saudi German Hospitals Group is listed as a regional player.
Does Burjeel Medical City have an API?
No public API is recorded for Burjeel Medical City.
What industry is Burjeel Medical City in?
Burjeel Medical City's product category is Quaternary Healthcare Services. Its primary akta.pro industry code is HLAFAAAN, International/Medical Tourism Hospital Systems, with a secondary code of HLAFAHAC, Oncology & Cancer Specialty Hospitals. Its NAICS code is 622110 and its SIC code is 8062.